Halozyme Therapeutics HALO Current ratio

Current ratio at other companies

West Pharmaceutical ServicesWST

2.8×0.0×

AMP

Amphastar PharmaceuticalsAMPH

2.4×-0.9×

AptarGroupATR

1.7×+0.4×

Opko HealthOPK

3.3×-0.1×

Amneal Pharmaceuticals, Inc.AMRX

2.2×+0.8×

Aquestive Therapeutics, Inc.AQST

4.1×-0.8×

FAQ

What is Halozyme Therapeutics's current ratio?

Halozyme Therapeutics (HALO) reported current ratio of 2.7× in Q2 2026.

How has Halozyme Therapeutics's current ratio changed year-over-year?

Halozyme Therapeutics's current ratio decreased by 67.6% year-over-year, from 8.4× to 2.7×.

What is the long-term trend for Halozyme Therapeutics's current ratio?

Over 5 years (2020 to 2025), Halozyme Therapeutics's current ratio has grown at a 28.8% compound annual growth rate (CAGR), from 1.3× to 4.7×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.